These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9172955)

  • 1. Pharmacokinetics and metabolism of selected prodrugs of PMEA in rats.
    Shaw JP; Louie MS; Krishnamurthy VV; Arimilli MN; Jones RJ; Bidgood AM; Lee WA; Cundy KC
    Drug Metab Dispos; 1997 Mar; 25(3):362-6. PubMed ID: 9172955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, in vitro antiviral evaluation, and stability studies of bis(S-acyl-2-thioethyl) ester derivatives of 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA) as potential PMEA prodrugs with improved oral bioavailability.
    Benzaria S; Pélicano H; Johnson R; Maury G; Imbach JL; Aubertin AM; Obert G; Gosselin G
    J Med Chem; 1996 Dec; 39(25):4958-65. PubMed ID: 8960556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral activity and pharmacokinetics in mice of oral bis(pivaloyloxymethyl)-9-(2-phosphonylmethoxyethyl)adenine, the bis(pivaloyloxymethyl) ester prodrug of 9-(2-phosphonylmethoxyethyl)adenine.
    Naesens L; Balzarini J; Bischofberger N; De Clercq E
    Antimicrob Agents Chemother; 1996 Jan; 40(1):22-8. PubMed ID: 8787873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transport, uptake, and metabolism of the bis(pivaloyloxymethyl)-ester prodrug of 9-(2-phosphonylmethoxyethyl)adenine in an in vitro cell culture system of the intestinal mucosa (Caco-2).
    Annaert P; Kinget R; Naesens L; de Clercq E; Augustijns P
    Pharm Res; 1997 Apr; 14(4):492-6. PubMed ID: 9144737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, oral bioavailability determination, and in vitro evaluation of prodrugs of the antiviral agent 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA).
    Starrett JE; Tortolani DR; Russell J; Hitchcock MJ; Whiterock V; Martin JC; Mansuri MM
    J Med Chem; 1994 Jun; 37(12):1857-64. PubMed ID: 8021925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral bioavailability of the antiretroviral agent 9-(2-phosphonylmethoxyethyl)adenine (PMEA) from three formulations of the prodrug bis(pivaloyloxymethyl)-PMEA in fasted male cynomolgus monkeys.
    Cundy KC; Fishback JA; Shaw JP; Lee ML; Soike KF; Visor GC; Lee WA
    Pharm Res; 1994 Jun; 11(6):839-43. PubMed ID: 7937523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the disposition of ester prodrugs of the antiviral agent 9-(2-phosphonylmethoxyethyl)adenine [PMEA] in Caco-2 monolayers.
    Annaert P; Gosselin G; Pompon A; Benzaria S; Valette G; Imbach JL; Naesens L; Hatse S; de Clercq E; Van den Mooter G; Kinget R; Augustijns P
    Pharm Res; 1998 Feb; 15(2):239-45. PubMed ID: 9523310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism and pharmacokinetics of novel oral prodrugs of 9-[(R)-2-(phosphonomethoxy)propyl]adenine (PMPA) in dogs.
    Shaw JP; Sueoko CM; Oliyai R; Lee WA; Arimilli MN; Kim CU; Cundy KC
    Pharm Res; 1997 Dec; 14(12):1824-9. PubMed ID: 9453075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced 9-(2-phosphonylmethoxyethyl)adenine secretion by a specific, indomethacin-sensitive efflux pump in a mutant 9-(2-phosphonylmethoxyethyl)adenine-resistant human erythroleukemia K562 cell line.
    Hatse S; De Clercq E; Balzarini J
    Mol Pharmacol; 1998 Nov; 54(5):907-17. PubMed ID: 9804626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic and antiretroviral activity in mice of oral [P(1),P(2)-bis[2-(adenin-9-yl)ethoxymethyl]phosphonate], a prodrug of 9-(2-phosphonylmethoxyethyl)adenine.
    Rossi L; Dominici S; Serafini S; Casabianca A; Cerasi A; Chiarantini L; Celeste AG; Cappellacci L; Franchetti P; Grifantini M; Magnani M
    J Antimicrob Chemother; 2002 Sep; 50(3):365-74. PubMed ID: 12205061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel hepatotrophic prodrugs of the antiviral nucleoside 9-(2-phosphonylmethoxyethyl)adenine with improved pharmacokinetics and antiviral activity.
    Biessen EA; Valentijn AR; De Vrueh RL; Van De Bilt E; Sliedregt LA; Prince P; Bijsterbosch MK; Van Boom JH; Van Der Marel GA; Abrahams PJ; Van Berkel TJ
    FASEB J; 2000 Sep; 14(12):1784-92. PubMed ID: 10973928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism and in vitro antiretroviral activities of bis(pivaloyloxymethyl) prodrugs of acyclic nucleoside phosphonates.
    Srinivas RV; Robbins BL; Connelly MC; Gong YF; Bischofberger N; Fridland A
    Antimicrob Agents Chemother; 1993 Oct; 37(10):2247-50. PubMed ID: 8257154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of pradefovir and PMEA in healthy volunteers after oral dosing of pradefovir.
    Lin CC; Xu C; Teng A; Yeh LT; Peterson J
    J Clin Pharmacol; 2005 Nov; 45(11):1250-8. PubMed ID: 16239358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ester prodrugs of acyclic nucleoside thiophosphonates compared to phosphonates: synthesis, antiviral activity and decomposition study.
    Roux L; Priet S; Payrot N; Weck C; Fournier M; Zoulim F; Balzarini J; Canard B; Alvarez K
    Eur J Med Chem; 2013 May; 63():869-81. PubMed ID: 23603046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisamidate Prodrugs of 2-Substituted 9-[2-(Phosphonomethoxy)ethyl]adenine (PMEA, adefovir) as Selective Inhibitors of Adenylate Cyclase Toxin from Bordetella pertussis.
    Česnek M; Jansa P; Šmídková M; Mertlíková-Kaiserová H; Dračínský M; Brust TF; Pávek P; Trejtnar F; Watts VJ; Janeba Z
    ChemMedChem; 2015 Aug; 10(8):1351-64. PubMed ID: 26136378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro, ex vivo, and in situ intestinal absorption characteristics of the antiviral ester prodrug adefovir dipivoxil.
    Annaert P; Tukker JJ; van Gelder J; Naesens L; de Clercq E; van Den Mooter G; Kinget R; Augustijns P
    J Pharm Sci; 2000 Aug; 89(8):1054-62. PubMed ID: 10906729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of novel bis(L-amino acid) ester prodrugs of 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA) with improved anti-HBV activity.
    Fu X; Jiang S; Li C; Xin J; Yang Y; Ji R
    Bioorg Med Chem Lett; 2007 Jan; 17(2):465-70. PubMed ID: 17074481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxicity of pivoxil esters of antiviral acyclic nucleoside phosphonates: adefovir dipivoxil versus adefovir.
    Zídek Z; Kmonícková E; Holý A
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):315-9. PubMed ID: 16601779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics, bioavailability, metabolism, and tissue distribution of cidofovir (HPMPC) and cyclic HPMPC in rats.
    Cundy KC; Bidgood AM; Lynch G; Shaw JP; Griffin L; Lee WA
    Drug Metab Dispos; 1996 Jul; 24(7):745-52. PubMed ID: 8818571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amidate prodrugs of 9-[2-(phosphonomethoxy)ethyl]adenine as inhibitors of adenylate cyclase toxin from Bordetella pertussis.
    Šmídková M; Dvoráková A; Tloust'ová E; Česnek M; Janeba Z; Mertlíková-Kaiserová H
    Antimicrob Agents Chemother; 2014; 58(2):664-71. PubMed ID: 24145524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.